Cannformatics
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Proprietary C-Res™ biomarker technology that measures metabolic biomarkers from saliva samples to quantify individual patient responses to medical cannabis, coupled with an AI-powered bioinformatics platform to optimize products, dosage, and consumption methods for personalized treatment.
Description Brand's website · 2026-10-04
Cannformatics delivers predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life. The company uses proprietary Cannabis-Responsive™ (C-Res™) biomarker technology and an AI-powered cannabinoid-based pharmacometabolomics approach to personalize medical cannabis treatment, focusing initially on neurological and neuropsychiatric disorders like autism and dementia.
Offerings
Core capabilities Brand's website · 2026-10-04
Cannabis-Responsive™ (C-Res™) biomarker technology; AI-powered bioinformatics platform for personalized treatment guidance.
Pricing Brand's website · 2026-10-04
Not disclosed.
Audience
Target industry Brand's website · 2026-10-04
Patients with neurological and neuropsychiatric disorders (e.g., autism spectrum disorder, dementia); Healthcare Providers (HCPs) recommending medical cannabis.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Cannformatics's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Cannformatics across the index.
Claim Cannformatics — free →Page last updated 2026-10-17.